Azmarda 200mg Tablet

Azmarda 200 mg Tablet is a prescription medicine used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults. It combines Sacubitril, a neprilysin inhibitor, and Valsartan, an angiotensin II receptor blocker (ARB), to improve heart function and reduce the workload on the heart. This combination helps the heart pump blood more efficiently, lowers blood pressure, reduces fluid retention, and decreases the risk of hospitalization due to heart failure and cardiovascular death. It also helps relieve symptoms such as shortness of breath, fatigue, and swelling of the feet or ankles. Azmarda is usually prescribed as part of a long-term heart failure management plan that includes lifestyle modifications such as a low-salt diet, regular physical activity as advised, weight management, and routine medical follow-up. Consistent treatment helps improve daily functioning and overall quality of life.

Azmarda 200 mg Tablet combines Sacubitril 97 mg and Valsartan 103 mg to provide advanced treatment for chronic heart failure with reduced ejection fraction. Sacubitril inhibits the enzyme neprilysin, increasing beneficial natriuretic peptides that relax blood vessels, remove excess sodium and water, reduce fluid overload, and decrease stress on the heart. Valsartan, an angiotensin II receptor blocker (ARB), blocks the effects of angiotensin II, preventing blood vessel constriction and reducing blood pressure and fluid retention. Together, these medicines improve the heart's pumping ability, relieve symptoms such as breathlessness, fatigue, and swelling, and significantly lower the risk of hospitalization and cardiovascular death. Long-term therapy helps slow the progression of heart failure while improving exercise capacity and daily functioning.

Combined with lifestyle changes such as limiting salt intake, maintaining a healthy weight, taking medicines consistently, and attending regular medical check-ups, Azmarda supports better cardiovascular health and enhances overall quality of life.

Precaution

• Use only under medical supervision.
• Do not use during pregnancy, as it may seriously harm the unborn baby.
• Inform your doctor if you have kidney disease, liver disease, low blood pressure, or a history of angioedema.
• Avoid potassium supplements or potassium-containing salt substitutes unless advised.
• Regular monitoring of blood pressure, kidney function, and potassium levels may be required.
• Maintain a 36-hour gap between stopping an ACE inhibitor and starting Azmarda to reduce the risk of angioedema.

Storage

• Store below 30°C.
• Keep in a cool, dry place.
• Protect from moisture and direct sunlight.
• Store in the original packaging.
• Keep out of reach of children.